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BACKGROUND: Major depressive disorder is a clinically heterogeneous psychiatric disorder with a polygenic
architecture. Genome-wide association studies have identiﬁed a number of risk-associated variants across the
genome and have reported growing evidence of NETRIN1 pathway involvement. Stratifying disease risk by genetic
variation within the NETRIN1 pathway may provide important routes for identiﬁcation of disease mechanisms by
focusing on a speciﬁc process, excluding heterogeneous risk-associated variation in other pathways. Here, we
sought to investigate whether major depressive disorder polygenic risk scores derived from the NETRIN1 signaling
pathway (NETRIN1-PRSs) and the whole genome, excluding NETRIN1 pathway genes (genomic-PRSs), were
associated with white matter microstructure.
METHODS: We used two diffusion tensor imaging measures, fractional anisotropy (FA) and mean diffusivity (MD), in
the most up-to-date UK Biobank neuroimaging data release (FA: n = 6401; MD: n = 6390).
RESULTS: We found signiﬁcantly lower FA in the superior longitudinal fasciculus (b = 2.035, pcorrected = .029) and
signiﬁcantly higher MD in a global measure of thalamic radiations (b = .029, pcorrected = .021), as well as higher MD in
the superior (b = .034, pcorrected = .039) and inferior (b = .029, pcorrected = .043) longitudinal fasciculus and in the
anterior (b = .025, pcorrected = .046) and superior (b = .027, pcorrected = .043) thalamic radiation associated with
NETRIN1-PRS. Genomic-PRS was also associated with lower FA and higher MD in several tracts.
CONCLUSIONS: Our ﬁndings indicate that variation in the NETRIN1 signaling pathway may confer risk for major
depressive disorder through effects on a number of white matter tracts.
Keywords: Biological pathway, Major depressive disorder, NETRIN1, Polygenic risk score, Thalamic radiations, White
matter
https://doi.org/10.1016/j.bpsc.2018.07.006Major depressive disorder (MDD) is a common and frequently
disabling psychiatric disorder and a leading cause of disability
worldwide (1). MDD is known to result from a complex
combination of environmental and genetic factors (2,3), and it
has a moderate heritability, of approximately 37% (4–6).
Genome-wide association studies (GWASs) suggest that at
least part of MDD’s heritability is due to the cumulative effect
of alleles of small effect size (7,8), and they have identiﬁed a
number of risk-associated genetic variants across the genome
(6,7,9–11). Signiﬁcant ﬁndings for GWAS analyses can also be
annotated to speciﬁc biological pathways, revealing underlying
cellular and molecular mechanisms.
Following several GWASs, the Psychiatric Genomics
Consortium has identiﬁed an aggregation of variants in severalª 2018 Society of Biological Psychiatry. Pub
N: 2451-9022 Biological Psychiatry: Cognitive Neurosciencespeciﬁc biological pathways (12,13). In MDD, Zeng et al. (14)
combined pathway and regional heritability analyses in two
independent samples and reported that the NETRIN1 signaling
pathway was involved in the genetic etiology of MDD. More-
over, polygenic risk scores (PRSs) calculated for this pathway
alone more accurately predicted MDD in one of the cohorts
compared with PRSs calculated for the whole genome.
Genetic variation within the NETRIN1 signaling pathway may
therefore capture more etiologically circumscribed liability for
MDD that is less susceptible to heterogeneous inﬂuences from
other biological pathways.
Animal studies have previously indicated that NETRIN1, by
binding to and activating NETRIN1 receptors such as deleted
in colorectal cancer (DCC), plays an important role inlished by Elsevier Inc. This is an open access article under the
CC BY license (http://creativecommons.org/licenses/by/4.0/).
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DCC was identiﬁed as playing a crucial role in thalamic axonal
growth, conﬁrming that interaction of NETRIN1 with DCC leads
to successful axon growth during central nervous system
development (16). GWASs of other traits related to MDD have
also shown an aggregation of variants in the NETRIN1 pathway
(17,18).
Previous studies have attempted to investigate psychiatric
disorders by examining relevant quantitative traits such as
brain structure or function (19). Differences in white matter
integrity as measured by diffusion tensor imaging have been
found between MDD patients and healthy participants in
numerous studies, although ﬁndings have been widely incon-
sistent (20–22). For example, Shen et al. (20) found signiﬁcantly
lower global white matter integrity in association ﬁbers and
thalamic radiations, as measured by fractional anisotropy (FA),
in MDD patients compared with that in healthy individuals.
More speciﬁcally, they also found lower FA in the left superior
longitudinal fasciculus, superior thalamic radiations, and
forceps major tracts in MDD patients. Lower white matter
integrity as measured by FA has also been found in adoles-
cents with MDD compared with that in age-matched healthy
individuals (21,22).
It has previously been shown that the NETRIN1 signaling
pathway is associated with MDD and white matter micro-
structure (14). Therefore, in the current study, we sought to
investigate the association between MDD risk–associated
variants in the NETRIN1 signaling pathway and white matter
integrity. We ﬁrst created PRSs for pathway single-nucleotide
polymorphisms (SNPs) (NETRIN1-PRSs) and SNPs excluded
from the pathway (genomic-PRSs). We then tested their as-
sociation with white matter integrity as measured by FA and
mean diffusivity (MD). We used the most up-to-date genetic
and imaging data available from the UK Biobank (UKB). We
hypothesized that NETRIN1-PRS would be signiﬁcantly asso-
ciated with white matter integrity, after adjustment for
genomic-PRS, indicating a potential role of the pathway in
MDD pathophysiology.
METHODS AND MATERIALS
UK Biobank
The UKB study consisted of 502,617 community-dwelling
ndividuals who were recruited between 2006 and 2010 in the
United Kingdom (http://biobank.ctsu.ox.ac.uk/crystal/ﬁeld.
cgi?id=200). The UKB received ethical approval from the
Research Ethics Committee (reference: 11/NW/0382). This
study has been approved by the UKB Access Committee
(Project No. 4844). Written informed consent was obtained
from all participants.
Study Population
In the most recent UKB imaging data release, 8839 individuals
(nfemale = 4639; nmale = 4200; mean age: 62.54 6 7.42 years;
age range: 45.17–79.33 years) completed a diffusion tensor
imaging assessment and a quality check by the UKB. In
addition to this, for the current study, individuals were
excluded if they participated in studies from the Psychiatric
Genomics Consortium MDD GWAS (23) or Generation92 Biological Psychiatry: Cognitive Neuroscience and Neuroimaging JaScotland (Scottish Family Health Study), or if the individuals
were biologically related to another participant, as the
Psychiatric Genomics Consortium MDD GWAS data set was
used in order to calculate PRS. Moreover, individuals whose
FA and MD values were .3 SDs above or below the mean
were not included in the study (Supplemental Tables S4 and
S5). This resulted in the inclusion of 6401 individuals with FA
values (nfemale = 3334; nmale = 3067; mean age: 62.60 6
7.37 years; age range: 45.92–78.42 years; ncontrol = 3736;
ncase = 2512) and 6390 individuals with MD
values (nfemale = 3327; nmale = 3063; mean age: 62.58 6
7.36 years; age range: 45.92–78.42 years; ncontrol = 3729;
ncase = 2508) and the exclusion of 19 and 30 individuals with
FA and MD values from a total sample of 6420, respectively.
Details of data exclusion as well as participant information for
the full data set (N = 6420) are shown in Supplemental
Tables S1 and S2.
SNP Annotation
Genic SNPs found in the NETRIN1 signaling pathway as taken
from Zeng et al.’s 2017 study (14) (Ngenes = 43; gene list is
presented in the Supplemental Table S3), and genic SNPs
excluded from the pathway were annotated using the program
ANNOVAR. ANNOVAR is a biostatistical tool used to annotate
genetic variants to functional genomic regions (24). In the
current study, we performed a gene-based annotation for
SNPs used in the largest available GWAS of MDD (N = 461,134
cases, of which 130,664 were MDD cases), carried out by
the Psychiatric Genomics Consortium (23), which includes
summary statistics from the personal genetics company
23andMe, Inc. (10). We deﬁned gene boundaries as an
extended region of 20 kb from transcription start sites and
transcription end sites. After SNPs were annotated to genes,
they were further mapped to the NETRIN1 signaling pathway.
All protein-coding genes within this ﬁle were annotated in
reference to hg 19. Intergenic SNPs were not included in the
annotated ﬁles. The resulting output ﬁle included the function
of each SNP, gene name, chromosome number, start position,
end position, reference and alternative alleles, odds ratio,
standard error, and p value for each variant.
Following functional annotation, a ﬁle containing the 43
gene names included in the NETRIN1 signaling pathway was
used as an input to extract gene-based SNPs located in the
pathway. For the genomic-PRSs, all gene-based SNPs,
excluding those implicated in the NETRIN1 signaling pathway,
were extracted. The two ﬁles were then used as input for the
creation of PRSs.
Genotyping and PRS Proﬁling
A total of 488,363 UKB blood samples (nfemale = 264,857;
nmale = 223,506; http://biobank.ctsu.ox.ac.uk/crystal/ﬁeld.cgi?
id=22001) were genotyped using two different arrays: UK
BiLEVE array (n = 49,949) (http://biobank.ctsu.ox.ac.uk/crystal/
refer.cgi?id=149600) and UKB Axiom array (n = 438,417)
(http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=149601). De-
tails of genotyping and quality control are described in more
detail by Hagenaars et al. (25) and Bycroft et al. (26).
Using the largest available GWAS of MDD, PRSs for each
individual were computed using PRSice (27) at ﬁve p valuenuary 2019; 4:91–100 www.sobp.org/BPCNNI
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risk alleles and weighting them by the strength of association
withMDD. PRSswere created both fromSNPs annotated to the
NETRIN1 signaling pathway and from SNPs from the rest of the
genome, thus resulting in separate PRS lists. PRSs were
created both with and without clump-based pruning of SNPs in
linkage disequilibrium (R2 = .25, 250-kb window). The primary
analysis reported in this manuscript concerns unpruned SNPs,
owing to the potential of causal variants within the NETRIN1
pathway to be in linkage disequilibrium with other variants, and
uses SNPs that met a signiﬁcance level of p = .5, which is in line
with previous studies (28,29). Secondary analyses with other
PRS p value thresholds, as well as with linkage disequilibrium
pruned SNPs, are presented in Supplemental Tables S6–S21.
Magnetic Resonance Imaging Acquisition
In this study, imaging-derived phenotypes produced by the
UKB were used. Magnetic resonance imaging acquisition and
preprocessing procedures for FA and MD values of white
matter tracts were performed by the UKB using standardized
protocols (https://biobank.ctsu.ox.ac.uk/crystal/docs/brain_
mri.pdf). Images were collected on a single Siemens Skyra
3.0T scanner (Siemens, Erlangen, Germany) with a standard
Siemens 32-channel head coil and were preprocessed using
FSL packages; parcellation of white matter tracts was
conducted using AutoPtx (30).
Summary data were composed of tract-averaged FA and
MD values for 15 major white matter tracts, of which 12 are
bilateral and three are unilateral. The white matter tracts were
also categorized into three separate subsets: association
ﬁbers (inferior fronto-occipital fasciculus, uncinate fasciculus,
cingulum bundle [gyrus and parahippocampal], and superior
and inferior longitudinal fasciculus), thalamic radiation ﬁbers
(anterior, superior, and posterior thalamic radiations), and
projection ﬁbers (forceps major and minor, corticospinal tract,
acoustic radiation, medial lemniscus, and middle cerebellar
peduncle). Global measures of FA and MD are referred to as
general factors of FA and MD.
Exclusion criteria comprised removal of scans with severe
normalization problems by the UKB. Moreover, individuals
whose FA and MD values were .3 SDs from the sample mean
were also excluded. Results for the full data set with outliers
included are also presented in Supplemental Tables S1 and
S2. Lastly, because the position of the head and radio-
frequency coil in the scanner may affect data quality as well
as imaging-derived phenotypes, three scanner brain-position
variables that may be used as confounding variables in
subsequent analyses were generated by the UKB: lateral brain
position X (http://biobank.ctsu.ox.ac.uk/crystal/ﬁeld.cgi?
id=25756), transverse brain position Y (http://biobank.ctsu.
ox.ac.uk/crystal/ﬁeld.cgi?id=25757), and longitudinal brain
position Z (http://biobank.ctsu.ox.ac.uk/crystal/ﬁeld.cgi?
id=25758). The three variables were included as covariates in
the statistical analysis described below.
Statistical Methods
All analyses were conducted using R (version 3.2.3) in a Linux
environment. To test the association between the NETRIN1
signaling pathway– and genomic pathway–derived unprunedBiological Psychiatry: Cognitive Neuroscience and NPRS lists, we used repeated-measures linear mixed-effects
models (function lme in package nlme) for 12 bilateral brain
regions, correcting for hemisphere, with age, age2, gender, 15
genetic principal components, three magnetic resonance
imaging head-position coordinates, and a genotype array set
as covariates. For unilateral tracts, global measures of FA and
MD, and tract categories, we used a general linear model
(function lm), using the same covariates as above, and without
hemisphere included as a separate term in the model. All
models included both the genomic-PRS and the NETRIN1-
PRS as predictor variables.
First, we tested the association between unpruned PRSs
(both NETRIN1-PRSs and genomic-PRSs) and global white
matter integrity. We applied principal component analysis on
the 27 white matter tracts (12 tracts in both the right and left
hemisphere and three unilateral tracts) to extract a latent
measure. Scores of the ﬁrst unrotated component of FA and
MD (variance explained = 37.52% for FA and 38.83% for MD)
were extracted and set as the dependent variable in a general
linear model to test association with both NETRIN1-PRS and
genomic-PRS.
We then examined the three categories of white matter
tracts by applying principal component analysis on the regions
involved in each, as a substantial proportion of white matter
microstructural properties shows substantial commonality
across these pathways (31). Scores of the ﬁrst unrotated
component of FA and MD were similarly extracted and set as
dependent variables in general linear modeling, as above.
Variance explained for each white matter tract subset was as
follows: association ﬁbers: 45.36% (FA), 50.76% (MD);
thalamic radiations: 60.85% (FA), 73.40% (MD); projection
ﬁbers: 35.54% (FA), 29.28% (MD).
Lastly, we tested the association between PRSs (both
NETRIN1-PRSs and genomic-PRSs) and each individual white
matter tract (N = 15). We used a repeated-effect linear model
for the 12 bilateral tracts and a random-effect general linear
model for the three unilateral tracts.
False discovery rate correction was applied separately for
the 15 individual tracts and for global and tract category
values.
Permutation Analysis
To establish that the effect of the NETRIN1 pathway–derived
PRS on white matter integrity as measured by FA and MD
was not due to chance, a circular genomic permutation was
applied to the pathway SNP genotypes (32). This was done by
placing all SNPs in the whole genome (excluding those in the
NETRIN1 pathway) in a circular genome, according to their
location. We then circularly permuted 1000 SNP lists with the
same set size as the NETRIN1 pathway. We created 1000 PRS
lists that were then ﬁtted in linear mixed-effects and general
linear models, depending on the white matter tract tested, and
their association with ﬁve white matter tracts and one tract
category, found to be signiﬁcantly associated with NETRIN1,
was tested.
RESULTS
Results presented below are signiﬁcant speciﬁcally to each
pathway. White matter tracts showing a signiﬁcant associationeuroimaging January 2019; 4:91–100 www.sobp.org/BPCNNI 93
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are described in the Supplement. Results for all individual
white matter tracts, tract categories, and global measures can
be found in Tables 1–4 and Figures 1–4.
The Effect of Unpruned NETRIN1-PRS and
Genomic-PRS on FA Measures of White Matter
Integrity
Global Measures. We ﬁrst tested the effect of
NETRIN1-PRS and genomic-PRS on global FA. Lower global
FA was signiﬁcantly associated with higher genomic-PRS
(b = 2.033, pcorrected = .011) only.
Tract Categories. We then tested the association between
NETRIN1-PRS and genomic-PRS and three subsets of white
matter tracts (association ﬁbers, thalamic radiations, and pro-
jection ﬁbers). Signiﬁcantly lower FA values in projection ﬁbers
were found for genomic-PRS (b = 2.028, pcorrected = .020) only.
Individual White Matter Tracts. Lastly, we investigated
the effect of NETRIN1-PRS and genomic-PRS on white matter
integrity in 15 individual white matter tracts. NETRIN1-PRS,
but not genomic-PRS, was associated with signiﬁcantly lower
FA in the superior longitudinal fasciculus (b = 2.035,
pcorrected = .029).Table 1. The Effect of Major Depressive Disorder NETRIN1-PRS
Matter Tracts (Fractional Anisotropy Values)
White Matter Tracts
NETRIN1-PRS
Effect
Size, b SD t Value p Value
p Value,
Correc
Association Fibers
Cingulate gyrus part of
cingulum
2.025 .011 22.323 .020 .152
Parahippocampal part of
cingulum
2.008 .011 20.780 .435 .544
Inferior fronto-occipital
fasciculus
2.023 .011 21.997 .046 .172
Inferior longitudinal
fasciculus
2.023 .011 22.029 .043 .172
Superior longitudinal
fasciculus
2.036 .012 23.093 .002 .030
Uncinate fasciculus 2.019 .011 21.747 .081 .202
Thalamic Radiations
Anterior thalamic radiation 2.022 .011 21.900 .057 .172
Posterior thalamic radiations 2.014 .011 21.267 .205 .308
Superior thalamic radiation 2.006 .012 20.493 .622 .718
Projection Fibers
Acoustic radiation .003 .011 0.306 .759 .814
Corticospinal tract .002 .011 0.173 .863 .863
Medial lemniscus 2.009 .010 20.842 .400 .544
Forceps major 2.016 .012 21.301 .193 .308
Forceps minor 2.018 .012 21.496 .135 .262
Middle cerebellar peduncle 2.018 .012 21.476 .140 .262
FDR, false discovery rate; Genomic-PRS, polygenic risk score derived fr
PRS, polygenic risk score derived from the NETRIN1 signaling pathway; PR
aR2 is the estimate of variance explained by each pathway, in %.
bStatistically signiﬁcant p value after false discovery rate correction.
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forceps major (b = 2.031, pcorrected = .043), forceps minor
(b = 2.031, pcorrected = .043) and uncinate fasciculus
(b = 2.031, pcorrected = .043). None of these tracts showed
signiﬁcant associations with NETRIN1-PRS.The Effect of Unpruned NETRIN1-PRS and
Genomic-PRS on MD Measures of White Matter
Integrity
Tract Categories. MD values for association ﬁbers
(b = .041, pcorrected = .001) and projection ﬁbers (b = .028,
pcorrected = .023) were found to be signiﬁcantly higher for
genomic-PRS, but not NETRIN1-PRS. MD values for thalamic
radiations were found to be signiﬁcantly higher in the
NETRIN1-PRS (b = .029, pcorrected = .021), whereas there was
no signiﬁcant association with genomic-PRS.
Individual White Matter Tracts. Within the 15 individual
white matter tracts, we found numerous areas signiﬁcantly
associated with both the NETRIN1-PRS and genomic-PRS.
With regards to NETRIN1-PRS, MD values were signiﬁcantly
higher in the inferior longitudinal fasciculus (b = .029,
pcorrected = .043), superior longitudinal fasciculus (b = .034,
pcorrected = .039), and anterior (b = .025, pcorrected = .046) andand Genomic-PRS at PRS Threshold 0.5 on Individual White
Genomic-PRS
FDR
ted R2a
Effect
Size, b SD t Value p Value
p Value, FDR
Corrected R2a
.062 2.019 .011 21.817 .069 .115 .038
.007 2.020 .011 21.873 .061 .115 .040
.053 2.028 .012 22.409 .016 .060 .076
.054 2.024 .012 22.056 .040 .115 .056
b .128 2.023 .012 21.988 .047 .115 .053
.102 2.032 .011 22.954 .003 .043b .102
.048 2.015 .011 21.310 .190 .238 .023
.020 2.022 .011 21.929 .054 .115 .047
.003 2.015 .012 21.246 .213 .244 .022
.001 2.013 .011 21.207 .228 .244 .016
.000 2.018 .011 21.632 .103 .154 .034
.008 2.003 .010 20.249 .803 .803 .001
.024 2.032 .012 22.626 .009 .043b .100
.032 2.032 .012 22.628 .009 .043b .099
.032 2.019 .012 21.536 .125 .170 .035
om the whole genome, excluding NETRIN1 pathway genes; NETRIN1-
S, polygenic risk score.
nuary 2019; 4:91–100 www.sobp.org/BPCNNI
Table 2. The Effect of Major Depressive Disorder Polygenic Risk Scores Derived From the NETRIN1 Signaling Pathway and
the Whole Genome, Excluding NETRIN1 Pathway Genes, at Polygenic Risk Score Threshold 0.5 on Global Fractional
Anisotropy and Three White Matter Tract Categories
NETRIN1-PRS Genomic-PRS
Effect
Size, b SD t Value p Value
p Value, FDR
Corrected R2a
Effect
Size, b SD t Value p Value
p Value, FDR
Corrected R2a
gFA 2.026 .012 22.197 .028 .056 .068 2.033 .012 -2.769 .006 .011b .109
Association Fibers 2.033 .012 22.762 .006 .023 .107 2.034 .012 -2.836 .005 .011 .113
Thalamic Radiations 2.018 .012 21.482 .138 .185 .032 2.022 .012 -1.855 .064 .064 .050
Projection Fibers 2.011 .012 20.904 .366 .366 .012 2.029 .012 -2.415 .016 .021b .083
FDR, false discovery rate; Genomic-PRS, polygenic risk score derived from the whole genome, excluding NETRIN1 pathway genes; gFA, global
fractional anisotropy; NETRIN1-PRS, polygenic risk score derived from the NETRIN1 signaling pathway; PRS, polygenic risk score.
aR2 is the estimate of variance explained by each pathway, in %.
bStatistically signiﬁcant p value after false discovery rate correction.
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these signiﬁcant associations were speciﬁc for NETRIN1-PRS.
In the genomic-PRS, we found signiﬁcantly higher MD
values in the cingulate gyrus (b = .035, pcorrected = .013) and
parahippocampal part of cingulum (b = .032, pcorrected = .014)
and in the uncinate fasciculus (b = .029, pcorrected = .018).
Permutation Analysis
NETRIN1-PRSs, but not genomic-PRSs, were found to be
individually signiﬁcantly associated with white matter micro-
structure in the following white matter tracts: superior longitu-
dinal fasciculus, as measured by lower FA, and superior and
inferior longitudinal fasciculus and anterior and superior
thalamic radiations, as well as thalamic radiations tract cate-
gory, as measured by higher MD. Therefore, we additionallyTable 3. The Effect of NETRIN1-PRS and Genomic-PRS at PR
Diffusivity Values)
White Matter Tracts
NETRIN1-PRS
Effect
Size, b SD t Value p Value
p Valu
Corr
Association Fibers
Cingulate gyrus part of cingulum .020 .011 1.877 .061 .1
Parahippocampal part of cingulum 2.002 .011 20.175 .861 .8
Inferior fronto-occipital fasciculus .027 .011 2.461 .014 .0
Inferior longitudinal fasciculus .029 .011 2.625 .009 .0
Superior longitudinal fasciculus .034 .011 3.009 .003 .0
Uncinate fasciculus .018 .010 1.698 .090 .1
Thalamic Radiations
Anterior thalamic radiation .025 .011 2.420 .016 .0
Posterior thalamic radiations .025 .011 2.326 .020 .0
Superior thalamic radiation .027 .010 2.758 .006 .0
Projection Fibers
Acoustic radiation .004 .010 0.375 .708 .7
Corticospinal tract .016 .011 1.399 .162 .2
Medial lemniscus .004 .011 0.357 .721 .7
Forceps major .018 .012 1.495 .135 .2
Forceps minor .019 .012 1.640 .101 .1
Middle cerebellar peduncle .013 .012 1.058 .290 .3
FDR, false discovery rate; PRS, polygenic risk score.
aR2 is the estimate of variance explained by each pathway, in %.
bStatistically signiﬁcant p value after false discovery rate correction.
Biological Psychiatry: Cognitive Neuroscience and Nperformed a circular genomic permutation analysis and found
that the variance explained by NETRIN1-PRSs in these tracts
was signiﬁcantly higher than that expected by chance (Table 5).DISCUSSION
In this study, we aimed to investigate whether PRSs calculated
from the NETRIN1 signaling pathway are signiﬁcantly and
speciﬁcally associated with white matter integrity while simul-
taneously modeling genomic-PRS in .6000 individuals. We
found signiﬁcant differences in white matter integrity in both
NETRIN1-PRSs and genomic-PRSs, for both FA and MD
values. Regarding FA values, for NETRIN1-PRSs but not for
genomic-PRSs, a signiﬁcant association was observed in the
superior longitudinal fasciculus. NETRIN1-PRSs alone were
signiﬁcantly associated with higher generalized thalamicS Threshold 0.5 on Individual White Matter Tracts (Mean
Genomic-PRS
e, FDR
ected R2a
Effect
Size, b SD t Value p Value
p Value, FDR
Corrected R2a
30 .040 .035 .011 3.317 .001 .014b .124
61 .000 .033 .011 3.109 .002 .014b .107
47 .075 .031 .011 2.807 .005 .019 .098
43b .086 .025 .011 2.216 .027 .067 .061
39b .116 .024 .011 2.133 .033 .071 .058
68 .085 .029 .010 2.815 .005 .019b .084
47b .065 .021 .011 2.028 .043 .080 .046
50 .062 .002 .011 0.157 .876 .876 .000
43b .074 .018 .010 1.771 .077 .096 .031
72 .002 .019 .011 1.853 .064 .087 .038
21 .025 .022 .011 1.921 .055 .082 .047
72 .001 .004 .011 0.396 .692 .741 .002
03 2.026 .028 .012 2.362 .018 .055 .019
68 2.063 .023 .012 1.958 .050 .082 2.051
63 .016 .010 .012 0.852 .394 .455 .010
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Table 4. The Effect of NETRIN1-PRS and Genomic-PRS at PRS Threshold 0.5 on Global Mean Diffusivity and Three White
Matter Tract Subsets
NETRIN1-PRS Genomic-PRS
Effect
Size, b SD t Value p Value
p Value, FDR
Corrected R2a
Effect
Size, b SD t Value p Value
p Value, FDR
Corrected R2a
gMD .028 0.011 2.417 .016 .031 .076 .034 .011 2.924 .003 .007 .111
Association Fibers .022 0.012 1.897 .058 .077 .048 .042 .012 3.591 .000 .001b .172
Thalamic Radiations .030 0.011 2.785 .005 .021b .089 .013 .011 1.232 .218 .218 .017
Projection Fibers .021 0.012 1.766 .077 .077 .045 .029 .012 2.380 .017 .023b .081
FDR, false discovery rate; Genomic-PRS, polygenic risk score derived from the whole genome, excluding NETRIN1 pathway genes; gMD, global
mean diffusivity; NETRIN1-PRS, polygenic risk score derived from the NETRIN1 signaling pathway; PRS, polygenic risk score.
aR2 is the estimate of variance explained by each pathway, in %.
bStatistically signiﬁcant p values after false discovery rate correction.
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CNNIradiations as measured by MD, as well as higher MD in the
superior and inferior longitudinal fasciculus and the anterior
and superior thalamic radiations. Genomic-PRSs were also
signiﬁcantly associated with FA and MD values in several
tracts.
One of the main ﬁndings in our paper was both a reduction
of FA and an increase of MD in the superior longitudinal
fasciculus in relation to NETRIN1-PRS. The superior longitu-
dinal fasciculus, a tract in association ﬁbers, connects the
frontal, temporal, parietal, and occipital lobes and has been
shown to be highly involved in MDD (33,34). FA reductions in
the superior longitudinal fasciculus have also been found in
previous studies combining genetic and neuroimaging tech-
niques (35), further indicating that the tract might be an
important biomarker of MDD. In addition to this ﬁnding, we
also found an increase in MD values in the inferior longitudinal
fasciculus, a tract connecting the temporal and occipital lobes.
Key areas in these two lobes include the amygdala and
hippocampus, which are known to be implicated in emotion
processing, a process that is disrupted in MDD (36). Previous
studies have found disrupted white matter integrity in this tractFigure 1. The effects of (left panel) major depressive disorder polygenic risk sc
(right panel) major depressive disorder PRS derived from the whole genome, excl
values of white matter tracts. The x-axis indicates the standardized effect size of
legend indicates the tract category belonging to each white matter tract. The err
96 Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Jain association with MDD using FA, indicating that it may play
an important role in the pathophysiology of MDD (35).
We also found an MD increase in the thalamic radiations
tract category. Thalamic radiations connect the thalamus with
numerous cortical areas (37) and are connected to various
cognitive processes, such as attention and wakefulness (38).
Thalamocortical axons play an important role during develop-
ment, as their projection from the dorsal thalamus (DT) trans-
mits sensory information to the neocortex (37). Thalamic
radiations have previously been linked to MDD in numerous
studies. For instance, a decrease in FA was found in the
thalamic radiations subset in a large UKB sample comparing
335 MDD patients with 754 healthy individuals (20). This tract
subset was also found to be signiﬁcantly associated with
higher PRS, indicating that there is a link between the sets of
tracts and a potential genetic predisposition to MDD (35).
NETRIN1 and its receptor DCC, one of the proteins in the
NETRIN1-pathway, have been previously implicated in
thalamic axonal growth. NETRIN1 promotes growth of thala-
mocortical axons by binding to and activating DCC, which is
expressed in the DT. Moreover, NETRIN1 has been shown toore (PRS) derived from the NETRIN1 signaling pathway (NETRIN1-PRS) and
uding NETRIN1 pathway genes (genomic-PRS), on fractional anisotropy (FA)
each pathway’s PRSs, and the y-axis indicates the white matter tracts. The
or bar represents the SD of the mean.
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Figure 2. The effects of (left panel) major depressive disorder polygenic risk score (PRS) derived from the NETRIN1 signaling pathway (NETRIN1-PRS) and
(right panel) major depressive disorder PRS derived from the whole genome, excluding NETRIN1 pathway genes (genomic-PRS), on fractional anisotropy (FA)
values of tract categories and global FA (gFA). The x-axis indicates the standardized effect size of each pathway’s PRS, and the y-axis indicates the tract
categories. The error bar represents the SD of the mean.
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CNNIenhance axonal growth in explants of the DT, as well as to
provide guidance from the DT to the cortex (37). It has also
been found that serotonin, which is highly implicated in MDD,
modulates the effect of NETRIN1 on embryonic thalamocort-
ical axons (37–39). The active involvement of NETRIN1 in
thalamocortical axonal growth, therefore, may explain our
ﬁndings, and it further conﬁrms that there is a potential linkFigure 3. The effects of (left panel) major depressive disorder polygenic risk sc
(right panel) major depressive disorder (PRS) derived from the whole genome, e
values of white matter tracts. The x-axis indicates the standardized effect size o
legend indicates the tract category belonging to each white matter tract. The err
Biological Psychiatry: Cognitive Neuroscience and Nbetween a biological pathway and speciﬁc neurobiological
markers in MDD.
Several other tracts also showed a signiﬁcant association of
FA (individually in forceps major and minor and uncinate
fasciculus, and in global measures of FA and projection ﬁbers)
and MD (individually in the cingulate part of the cingulum,
parahippocampal part of cingulum, and uncinate fasciculusore (PRS) derived from the NETRIN1 signaling pathway (NETRIN1-PRS) and
xcluding NETRIN1 pathway genes (genomic-PRS), on mean diffusivity (MD)
f each pathway’s PRS, and the y-axis indicates the white matter tracts. The
or bar represents the SD of the mean.
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Figure 4. The effects of (left panel) major depressive disorder PRS derived from the NETRIN1 signaling pathway (NETRIN1-PRS) and (right panel) major
depressive disorder PRS derived from the whole genome, excluding NETRIN1 pathway genes (genomic-PRS), on mean diffusivity (MD) values of tract cat-
egories and global MD (gMD). The x-axis indicates the standardized effect size of each pathway’s PRS, and the y-axis indicates the tract categories. The error
bar represents the SD of the mean.
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with genomic-PRS, most of which have also been previously
associated with MDD (20,35). This evidence further conﬁrms
that there is an association between genetic predisposition to
MDD and disruptions in white matter integrity, also for variants
that lie outside the NETRIN1-DCC pathway. As such, these
ﬁndings suggest that both PRS lists affect integrity across the
white matter tracts, each with localized, pronounced effects in
speciﬁc tracts.
The current study has several strengths and a few potential
limitations. First, to our knowledge it is the largest combined
genetic and neuroimaging study investigating the effect of PRS
derived from a speciﬁc biological pathway on white matter
integrity. Moreover, our analysis consisted of a population-
based sample of ambulant individuals recruited to the UKB.
Our ﬁndings might therefore be robust and generalizable toTable 5. Permutation Results for NETRIN1-PRS at PRS Thres
Signiﬁcant Tract Category
White Matter Tract or Tract Category
Effect Size of Regressio
NETRIN1 Pathway
Superior Longitudinal Fasciculus (FA) 2.035
Superior Longitudinal Fasciculus (MD) .034
Inferior Longitudinal Fasciculus (MD) .029
Anterior Thalamic Radiations (MD) .025
Superior Thalamic Radiations (MD) .027
Thalamic Radiations (MD) .029
FA, fractional anisotropy; MD, mean diffusivity; NETRIN1-PRS, polygenic
risk score.
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such as the UKB are not immune to biases associated with
study participation, such as collider bias (40).
In addition to the large sample, the fact that NETRIN1-PRS
are derived from only 43 genes, comprising approximately
0.215% of the genes in the whole genome (N z 20,000),
suggests that MDD risk–associated variation exerts a dispro-
portionate inﬂuence on white matter microstructure. Our ﬁnd-
ings are further supported by permutation analysis. The
association between the NETRIN1 pathway and white matter
integrity is therefore likely to reﬂect the importance of a speciﬁc
pathway in the pathophysiology of MDD.
The NETRIN1 signaling pathway has previously been found
to be implicated in MDD (14). In the current study, we were able
to ﬁnd speciﬁc neurobiological structural connectivity markers
associated with this biological pathway. To our knowledge, thehold 0.5 on Five Signiﬁcant White Matter Tracts and One
n Regression NETRIN1
Pathway t Score
NETRIN1 Calculated
Permutation p Value
23.093 .004
3.008 .004
2.624 .014
2.419 .023
2.757 .007
2.785 .008
risk score derived from the NETRIN1 signaling pathway; PRS, polygenic
nuary 2019; 4:91–100 www.sobp.org/BPCNNI
NETRIN1 PRS and White Matter Microstructure in MDD
Biological
Psychiatry:
CNNIcurrent study is the ﬁrst one to note an association between
PRSs derived speciﬁcally from the NETRIN1 signaling pathway
and several white matter tracts in a large genetic and neuro-
imaging data set. This indicates that these brain structures
may be involved in the manifestation of genetic risk of MDD
and ultimately the etiology of the disorder.
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